TAIDOC TECHNOLOGY CORP (4736) - Cash Flow Conversion Efficiency
Based on the latest financial reports, TAIDOC TECHNOLOGY CORP (4736) has a cash flow conversion efficiency ratio of 0.024x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$238.93 Million ≈ $7.53 Million USD) by net assets (NT$9.96 Billion ≈ $313.66 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see how much is TAIDOC TECHNOLOGY CORP worth for the company's overall valuation and market capitalisation.
TAIDOC TECHNOLOGY CORP - Cash Flow Conversion Efficiency Trend (2009–2025)
This chart illustrates how TAIDOC TECHNOLOGY CORP's cash flow conversion efficiency has evolved over time, based on yearly financial data.
TAIDOC TECHNOLOGY CORP Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of TAIDOC TECHNOLOGY CORP ranked by their cash flow conversion efficiency. Explore TAIDOC TECHNOLOGY CORP cash flow quality index to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Lanner Electronics
TWO:6245
|
0.034x |
|
Sejin Heavy Industries Co Ltd
KO:075580
|
0.100x |
|
Nanjing Inform Storage Equip
SHG:603066
|
-0.012x |
|
Airnet Technology Inc
NASDAQ:ANTE
|
0.367x |
|
Misun Technology Co Ltd
SHE:301577
|
N/A |
|
Beijing Bohui Science & Technology Co Ltd
SHG:688004
|
-0.017x |
|
EQV Ventures Acquisition Corp.
NYSE:EQV
|
-0.003x |
|
Samhi Hotels Limited
NSE:SAMHI
|
0.090x |
Annual Cash Flow Conversion Efficiency for TAIDOC TECHNOLOGY CORP (2009–2025)
The table below shows the annual cash flow conversion efficiency of TAIDOC TECHNOLOGY CORP from 2009 to 2025. View latest TAIDOC TECHNOLOGY CORP stock price today for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-09-30 | NT$10.12 Billion ≈ $318.98 Million |
NT$853.39 Million ≈ $26.89 Million |
0.084x | +542.57% |
| 2024-09-30 | NT$9.52 Billion ≈ $300.01 Million |
NT$-181.37 Million ≈ $-5.71 Million |
-0.019x | -115.05% |
| 2023-09-30 | NT$9.26 Billion ≈ $291.71 Million |
NT$1.17 Billion ≈ $36.93 Million |
0.127x | -60.58% |
| 2022-09-30 | NT$9.99 Billion ≈ $314.89 Million |
NT$3.21 Billion ≈ $101.12 Million |
0.321x | +27.70% |
| 2021-09-30 | NT$7.63 Billion ≈ $240.53 Million |
NT$1.92 Billion ≈ $60.48 Million |
0.251x | -1.04% |
| 2020-09-30 | NT$6.62 Billion ≈ $208.59 Million |
NT$1.68 Billion ≈ $53.00 Million |
0.254x | +5.41% |
| 2019-09-30 | NT$4.51 Billion ≈ $142.12 Million |
NT$1.09 Billion ≈ $34.26 Million |
0.241x | +23.91% |
| 2018-09-30 | NT$4.02 Billion ≈ $126.75 Million |
NT$782.66 Million ≈ $24.66 Million |
0.195x | +18.66% |
| 2017-09-30 | NT$3.18 Billion ≈ $100.15 Million |
NT$521.21 Million ≈ $16.42 Million |
0.164x | -20.71% |
| 2016-09-30 | NT$3.08 Billion ≈ $96.90 Million |
NT$636.01 Million ≈ $20.04 Million |
0.207x | +18.63% |
| 2015-09-30 | NT$2.91 Billion ≈ $91.80 Million |
NT$507.88 Million ≈ $16.00 Million |
0.174x | -26.06% |
| 2014-09-30 | NT$2.49 Billion ≈ $78.42 Million |
NT$586.76 Million ≈ $18.49 Million |
0.236x | +32.93% |
| 2013-09-30 | NT$2.11 Billion ≈ $66.57 Million |
NT$374.74 Million ≈ $11.81 Million |
0.177x | +40.30% |
| 2012-09-30 | NT$1.96 Billion ≈ $61.74 Million |
NT$247.71 Million ≈ $7.80 Million |
0.126x | -28.47% |
| 2011-09-30 | NT$2.05 Billion ≈ $64.73 Million |
NT$363.06 Million ≈ $11.44 Million |
0.177x | +460.23% |
| 2010-09-30 | NT$2.27 Billion ≈ $71.41 Million |
NT$71.50 Million ≈ $2.25 Million |
0.032x | -88.51% |
| 2009-09-30 | NT$1.70 Billion ≈ $53.59 Million |
NT$466.80 Million ≈ $14.71 Million |
0.274x | -- |
About TAIDOC TECHNOLOGY CORP
TaiDoc Technology Corporation manufactures and markets medical devices in Taiwan and internationally. The company offers In vitro diagnostics products, including multiple parameter monitoring systems, point of care testing devices, and lancet and lancing devices; vet health care products comprise blood glucose and calcium meters, and blood ketone meters; and medical devices, such as nebulizers, t… Read more